Agreement Between LIAISON® MeMed BV® Finding and Clin-ical Impression Regarding the Presence of Bacterial Infection; A Letter to Editor
Journal of Practical Emergency Medicine,
Vol. 12 No. 1 (2025),
1 Dey 2025
,
Page e10
https://doi.org/10.22037/jpem.v12i1.48720
Abstract
The MeMed BV® (MMBV) is a semi-quantitative assay that uses chemiluminescent immunoassay technology to measure three host proteins in adult and pediatric serum samples. The purpose of this pilot study was to assess the potential utility of the LIAISON® MeMed BV® (LMMBV) test as part of the diagnostic work-up for adult patients with suspected acute respiratory infections, sepsis, and/or fever without source presenting to the emergency department, including patients that had potential immune-modulating conditions or trauma that would have excluded them from previously published evaluations of this assay. The LMMBV assay identified suspected bacterial infections with a positive percent agreement (PPA) of 94.1% and a negative percent agreement (NPA) of 41.7% compared to overall clinical impression. These pilot findings suggest that the LMMBV assay performs with a high PPA for bacterial infections compared to clinical impression documented in the electronic health record (EHR), even in an adult patient population with potentially confounding conditions and co-morbidities that have not been studied before; research to further explore expanded use in this population is warranted. Laboratory testing, even when equivocal to the clinical impression, can improve healthcare providers’ confidence when making decisions of antimicrobial stewardship helping them justify (both to themselves and their patients) not empirically prescribing antibiotics in cases that the likelihood of a bacterial infection is low.
- Respiratory tract infections
- IP-10 protein, human
- C-reactive protein
- Communicable diseases
- Diagnosis
- Immunoassay
How to Cite
References
1. Bachur RG, Kaplan SL, Arias CA, Ballard N, Carroll KC, Cruz AT, et al. A rapid host-protein test for differentiating bacterial from viral infection: Apollo diagnostic accuracy study. J Am Coll Emerg Physicians Open. 2024;5(3):e13167.
2. Denina M, Minero CM, Vitale R, Pini CM, Operti M, Garazzino S, et al. Real-World Application of the MeMed BV Test in Differentiating Bacterial, Viral, and Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia. J Infect Dis. 2025;231(2):540–1.
3. Mor M, Paz M, Amir L, Levy I, Scheuerman O, Livni G, et al. Bacterial vs viral etiology of fever: A prospective study of a host score for supporting etiologic accuracy of emergency department physicians. PLoS One. 2023;18(1):e0281018.
4. Novak D, Masoudi A, Shaukat B, Kabariti S, Drapkin J, Christian M, et al. MeMed BV testing in emergency department patients presenting with febrile illness concerning for respiratory tract infection. Am J Emerg Med. 2023;65:195–9.
5. Steckiewicz KP, Wujtewicz MA, Okrągły M, Aszkiełowicz A, Dąbrowska M, Owczuk R. Clinical usefulness of a host signature based on TRAIL, IP10, and CRP (MeMed BV) as infection biomarkers in intensive care units' patients. A retrospective observational study. Clin Biochem. 2024;126:110748.
6. Noni M, Kalogera E, Xydia A, Paradeisis G, Spyridopoulou K, Zachariadou L, et al. Validation of a Rapid Host-Protein Score to Discriminate Bacterial from Viral Infections in Hospitalized Febrile Pediatric Patients. Children (Basel). 2025;12(3).
7. Carroll KC. Assessment of MeMed BV assays for differentiating between bacterial and viral respiratory infections. Expert Rev Mol Diagn. 2024;24(10):873–84.
8. MeMed Inc. MeMed BV Instructions for Use. 2021.
9. Cabañas Morafraile J, de Rafael González E, Serrano Martín L, Rubio Díaz R, Torres Fernández M, Heredero Gálvez E, et al. Diagnostic power of LIAISON MeMed VB® for bacterial infection in adults patients seen in Emergency Departments due to infections. Rev Esp Quimioter. 2024;37(6):486–97.
- Abstract Viewed: 44 times
- PDF Downloaded: 52 times
